87081-467 : Desferal 500 mg/5ml Intravenous; Subcutaneous Injection, Powder, for Solution
| NDC: | 87081-467 |
| Labeler: | Mitem Pharma |
| Product Type: | Human Prescription Drug |
| Drug Name: | Desferal |
| Dosage Form: | Intravenous; Subcutaneous Injection, Powder, for Solution |
| Application #: | NDA016267 |
| Rev. Date: |
NDC Package Codes:
- 87081-467-91: 4 ML IN 1 VIAL (87081‑467‑91)
Active Ingredients:
- Deferoxamine Mesylate
Dosage Strength:
- 500 mg/5mL
Pharmaceutical Classes:
- Iron Chelating Activity [MoA]
- Iron Chelator [EPC]
Related Products:
Based on records with the same trade name.- 0078-0347 Desferal 2000 mg/1 Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Novartis Pharmaceuticals Corporation
- 0078-0467 Desferal 500 mg/1 Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Novartis Pharmaceuticals Corporation
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 87080-106Next: 87083-001 >
Related Discussions:
desferal
...
...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.